Institutional Ownership
Biomarin Pharmaceutical Inc
CUSIP 09061GAK7NOTE 1.250% 5/1BMRNQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
14
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Focus Partners Wealth | 3.35M | $3.22M |
| 2 | State Of Wisconsin Investment Board | 3.00M | $2.89M |
| 3 | Bnp Paribas Asset Management Holding S.A. | 2.90M | $2.79M |
| 4 | Janus Henderson Group PLC | 1.60M | $1.54M |
| 5 | Davenport & Co LLC | 10.0K | $964.7K |
| 6 | Sei Investments Co | 371.0K | $357.3K |
| 7 | Oddo Bhf Asset Management Sas | 225 | $218.2K |
| 8 | Oppenheimer Asset Management Inc. | 176.0K | $169.5K |
| 9 | Stephens Inc /Ar/ | 54.0K | $52.0K |
| 10 | Mml Investors Services, LLC | 49.0K | $47.2K |